COLIN STRACK: Open Payments
NPI 1003274192 · LOVELAND, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$926 in 45 payments from 14 companies in 2025. Trend: 2023 $972 · 2024 $781 · 2025 $926
Food & beverage: $895Education: $31
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $254 |
| Regeneron Healthcare Solutions, Inc. | 5 | $132 |
| Janssen Biotech, Inc. | 5 | $111 |
| Gilead Sciences, Inc. | 4 | $87 |
| PFIZER INC. | 4 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $57 |
| GENZYME CORPORATION | 2 | $52 |
| Intercept Pharmaceuticals, Inc. | 2 | $31 |
| Celltrion USA Inc. | 2 | $28 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, RINVOQ, VELSIPITY, ENTYVIO, LINZESS, OCALIVA.
Industry payments across CO — which companies pay providers there.
